Therapy to Improve Reaching Movement in Upper Limb

NCT ID: NCT03508037

Last Updated: 2018-09-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-03-12

Study Completion Date

2019-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Strokes are caused by a bleed in the brain and can be life threatening. One common consequence is upper limb impairment. This causes stroke patients to be unable to use their arms and upper body to do simple tasks such as reaching or grasping. Currently, people with stroke undergo rehabilitation, which is usually done through a physical and occupational (daily living skills) therapies to improve their mobility (movement) with their upper limbs. However, this kind of treatment has limitations and often cannot help patients regain total mobility. There are alternative rehabilitation treatments that use new methods and technologies that may be able to help patients with stroke. Neuromodulaton therapies using brain-computer interfaces (BCI), which connects brain signals directly to a computer, have the potential to help patients. This type of therapy uses assistive devices such as electrical stimulation (electrical shocks or waves) and robots to help restore function to the areas affected by stroke. The aim of this study is to evaluate and the potential benefits that can be achieved by using assistive devices in rehabilitation sessions with stroke patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Impairment Upper Limb

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

The subject receives the Functional Electrical Stimulation (FES) when he or she has the intention to move. It is obtained through electroencephalography.

Group Type EXPERIMENTAL

Neuromodulation electroencephalographic signals and functional electrical stimulation based

Intervention Type OTHER

First, the subject performs twenty reaching movements without assistance with the damaged arm resting on a robot (ArmeoSpring), with the aim of finding the Contingent Negative Variation (CNV). Then, he or she executes five courses of twenty movements receiving functional electrical stimulation (FES), either at the moment in which he or she wishes to move (experimental group), or half a second before or after (control group).

Control group

The subject receives the Functional Electrical Stimulation (FES) after o before (0.5 seconds) when he or she has the intention to move. It is obtained through electroencephalography.

Group Type ACTIVE_COMPARATOR

Neuromodulation electroencephalographic signals and functional electrical stimulation based

Intervention Type OTHER

First, the subject performs twenty reaching movements without assistance with the damaged arm resting on a robot (ArmeoSpring), with the aim of finding the Contingent Negative Variation (CNV). Then, he or she executes five courses of twenty movements receiving functional electrical stimulation (FES), either at the moment in which he or she wishes to move (experimental group), or half a second before or after (control group).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neuromodulation electroencephalographic signals and functional electrical stimulation based

First, the subject performs twenty reaching movements without assistance with the damaged arm resting on a robot (ArmeoSpring), with the aim of finding the Contingent Negative Variation (CNV). Then, he or she executes five courses of twenty movements receiving functional electrical stimulation (FES), either at the moment in which he or she wishes to move (experimental group), or half a second before or after (control group).

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Neuromodulation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* With response to Transcranial Magnetic Stimulation (TMS)
* Cortical or sub-cortical stroke patients
* With a score in the range of 22-44 on Fugl-Meyer scale or 2-4 on the Motor Assessment Scale
* With visible cortical patterns registered by BCI
* Subjects that tolerate electrical stimulation and that present a motor response
* Subjects with cognitive ability to follow instructions and perform the indicated tasks

Exclusion Criteria

* Subjects with neurological injury prior to stroke or more than two events
* Patients with implanted devices
* Patients with severe motor paralysis
* Patients with epilepsy
* Patient with vision or hearing impairment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centro de Referencia Estatal de Atención Al Daño Cerebral

OTHER

Sponsor Role collaborator

Centro Universitario La Salle

OTHER

Sponsor Role collaborator

Cajal Institute of the Spanish National Research Council

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Oscar Herrero Gimenez

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jose Luis Pons

Role: PRINCIPAL_INVESTIGATOR

Centro Superior de Investigaciones Científicas (CSIC)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centro de Referencia Estatal de Atención al Daño Cerebral (CEADAC)

Madrid, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Oscar Herrero

Role: CONTACT

+ 34 645 16 31 66

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Carlos Gonzalez

Role: primary

+34 696993123

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CSEULS-PI-106/2016

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

BCI Post-stroke Neurorehabilitation
NCT02404857 COMPLETED NA
Hand Rehabilitation Study for Stroke Patients
NCT03148106 ACTIVE_NOT_RECRUITING NA
Rehabilitation of the Stroke Hand at Home
NCT01144715 COMPLETED PHASE4
Reaching in Stroke
NCT02654951 COMPLETED NA